

***

[(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)][(diagnostic performance,using,recently introduced CXCR4-targeted PET probe,1.0), (patients,is with,breast cancer,1.0), (aim,assess,diagnostic performance in patients,1.0), (aim,assess,performance in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging,1.0), (aim,assess,performance of PET imaging in patients with breast cancer,1.0), (performance,using,recently introduced CXCR4-targeted PET probe,1.0), (performance,using,PET probe,1.0), (aim,assess,performance,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance of PET imaging in patients,1.0), (aim,assess,diagnostic performance of CXCR4-directed PET imaging in patients,1.0), (aim,assess,performance of PET imaging,1.0), (performance,using,CXCR4-targeted PET probe,1.0), (aim,assess,diagnostic performance of PET imaging,1.0), (diagnostic performance,using,PET probe,1.0), (aim,assess,diagnostic performance of PET imaging in patients,1.0), (performance,using,recently introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging,1.0), (aim,assess,diagnostic performance,1.0), (diagnostic performance,using,CXCR4-targeted PET probe,1.0), (performance,using,introduced CXCR4-targeted PET probe,1.0), (diagnostic performance,using,introduced CXCR4-targeted PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients,1.0), (diagnostic performance,using,introduced PET probe,1.0), (aim,assess,diagnostic performance in patients with breast cancer,1.0), (aim,assess,diagnostic performance of PET imaging in patients with breast cancer,1.0), (performance,using,introduced PET probe,1.0), (aim,assess,performance of CXCR4-directed PET imaging in patients with breast cancer,1.0), (aim,assess,performance in patients with breast cancer,1.0), (diagnostic performance,using,recently introduced PET probe,1.0), (diagnostic performance,is in,patients with breast cancer,1.0)]
Number of triplets 5 :	0